Videos

Embryologist shortages and emerging AI technologies are transforming IVF laboratories, driving the need for integrated systems and standardized workflows.

Emerging AI tools are improving efficiency and precision in IVF labs, but high costs and training limitations still prevent them from replacing manual expertise.

Sleep specialist Carleara Weiss, MD, PhD, MSH, RN, outlines the hormonal, physiological, and educational factors affecting sleep in menopausal women

FemBloc, a transcervical, incision-free method of permanent birth control, is advancing through its pivotal trial after strong early safety data.

Review of OASIS-1 through OASIS-4 trial results demonstrating consistent improvements in VMS frequency, severity, and sleep quality.

The experts examine the dual NK3/NK1 mechanism of elinzanetant and its broader potential to address mood and sleep disturbances.

New research shows that a single prophylactic antibiotic dose lowers clinically relevant wound complications after second-degree tears or episiotomy.

A study found that self-administered clinical hypnosis significantly reduced hot flashes and improved sleep.

Michael Warren, MD, MPH, FAAP, outlines how expanding maternity care deserts and rising chronic disease rates are driving poor maternal outcome.

Sarah M. Crafton, MD, discusses how a new investigational robotic platform is expanding minimally invasive options and improving outcomes for patients.

Research found only modest neonatal outcome differences between general and neuraxial anesthesia during cesarean delivery.

Michael Warren, MD, MPH, FAAP, explains the nation’s stagnant preterm birth rate and widening disparities highlighted in the 2025 report.

Deborah Anderson, PhD, highlights the need for improved contraception access, education, and research support worldwide.

Discussion highlights fezolinetant’s rapid-onset efficacy, favorable tolerability, and safety findings as the first NK3 antagonist approved for VMS.

The panel reviews the role of NK1 and NK3 receptors in thermoregulation and symptom genesis, setting the stage for targeted therapy.

Jessica Golbus, MD, discusses the benefits of cardiac rehabilitation and innovative solutions to improve access and engagement.

Jun Wang, PhD, and Rajesh Miranda, PhD, outline why prevention alone is insufficient and emphasize the need for early diagnosis for children affected by prenatal alcohol exposure.

Drawing on work by Rajesh Miranda, PhD, and Jun Wang, PhD, new evidence shows that prenatal alcohol exposure alters cognitive flexibility.

A phenotype linking hypertensive disorders of pregnancy with preterm birth and large-for-gestational-age infants may reshape understanding of maternal cardiovascular risk.

Experts contrast traditional hormone therapy with newer nonhormonal agents, outlining patient suitability and limitations.

Discussion centers on the daily and long-term consequences of untreated VMS, including sleep disruption, fatigue, and cognitive decline.

Panelists describe how hypothalamic KNDy neuron dysregulation drives hot flashes and night sweats following estrogen decline.

Pauline Maki, MD, welcomes the expert panel and introduces the focus on novel mechanisms and emerging therapies for vasomotor symptoms in menopause.

Declining national screening rates highlight the need for increased investment, education, and innovative approaches to expand access.

Study finds women on hormone therapy lost more weight with tirzepatide, though researchers stress association—not causation—needs confirmation.

Fertility expert Lucky Sekhon, MD, and Olympic gold medalist Tara Lipinski discuss the psychological challenges of infertility.

New data suggest hormone therapy may increase autoimmune disease risk in postmenopausal women, highlighting the need for clinical vigilance.

Experts highlight future research in personalized menopause care, exploring hormone safety, the microbiome, cognition, and metabolic health.

Experts compare hormone and nonhormonal options for menopause, emphasizing tailored care, persistent symptom relief, and safe use of local estrogen.

Experts discuss how neurokinin receptor antagonists offer rapid, durable, and nonhormonal relief for vasomotor symptoms, reshaping menopause care.